The urgency of effective responses to the COVID-19 pandemic and the reliance of many low-income countries on imports of medical products, requires new approaches to regulation of these products. The challenge will be particularly acute for the new tests to identify infection, drugs to alleviate symptoms and machines to aid recovery as well as vaccines that are all expected to be developed in the coming months. Increased transparency, information sharing...
Подробнее
ПОДРОБНАЯ ИНФОРМАЦИЯ
-
2020/05/21
-
Краткие сведения
-
148792
-
1
-
1
-
2020/05/26
-
Disclosed
-
Streamlining Technical Measured on Medical Products to Combat COVID-19
-
medical product